Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 34.34 | N/A |
| PEG Ratio (TTM) | 0.03 | N/A |
| P/S Ratio (TTM) | 3.15 | N/A |
| P/B Ratio (TTM) | 2.04 | N/A |
| P/FCF Ratio (TTM) | 11.93 | N/A |
| Price to 5YR AVG Earnings Ratio | 27.62 | N/A |
| Price to 5YR AVG FCF Ratio | 16.36 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.45% | N/A |
| ROE (TTM) | 6.26% | N/A |
| Net Profit Margin (TTM) | 9.16% | N/A |
| ROIC 5YR AVG | 9.82% | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3,916.18% | -15.04% | -26.22% |
| Revenue | 3.94% | 13.32% | 9.22% |
| Net Income | 4,018.12% | -14.59% | -25.59% |
| Cash Flow | 13.43% | -0.16% | -2.70% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.20 | N/A |
| Quick Ratio (TTM) | 1.98 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 5.21 | N/A |
| LTL to 5YR AVG FCF | 0.26 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.96% | N/A |